| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2023 | Jun 14, 2023 | Tourmaline Bio, Inc. | Director | Sell | 32.5 | -44,020 | -0.86% | ✗ | $112.3K |
| Jun 7, 2023 | Jun 9, 2023 | Tourmaline Bio, Inc. | Director | Sell | 20.0 | -141,062 | -2.68% | ✗ | $342.5K |
| Jun 5, 2023 | Jun 7, 2023 | Tourmaline Bio, Inc. | Director | Sell | 32.5 | -33,390 | -0.63% | ✗ | $84.4K |
| Jun 1, 2023 | Jun 5, 2023 | Tourmaline Bio, Inc. | Director | Sell | 32.5 | -31,531 | -0.59% | ✗ | $79.8K |
| Apr 21, 2023 | Apr 25, 2023 | Tourmaline Bio, Inc. | Director | Sell | 43.8 | -15,004 | -0.28% | ✗ | $35.2K |
| Apr 19, 2023 | Apr 21, 2023 | Tourmaline Bio, Inc. | Director | Sell | 22.5 | -68,743 | -1.27% | ✗ | $156.4K |
| Apr 17, 2023 | Apr 19, 2023 | Tourmaline Bio, Inc. | Director | Sell | 20.0 | -148,982 | -2.68% | ✗ | $319.3K |
| Mar 17, 2023 | Apr 7, 2023 | Tourmaline Bio, Inc. | Director | Sell | 53.8 | -10,436 | -0.19% | ✓ | $21.5K |
| Mar 3, 2023 | Apr 7, 2023 | Tourmaline Bio, Inc. | Director | Sell | 53.8 | -6,806 | -0.12% | ✓ | $14K |
| Mar 1, 2023 | Apr 7, 2023 | Tourmaline Bio, Inc. | Director | Sell | 58.8 | -29 | 0.00% | ✓ | $59.5 |
| Feb 21, 2023 | Apr 7, 2023 | Tourmaline Bio, Inc. | Director | Sell | 56.3 | -3,500 | -0.06% | ✓ | $7.2K |
| Feb 16, 2023 | Apr 7, 2023 | Tourmaline Bio, Inc. | Director | Sell | 53.8 | -6,551 | -0.12% | ✓ | $13.4K |
| Mar 17, 2023 | Mar 20, 2023 | Tourmaline Bio, Inc. | Director | Sell | 51.3 | -10,436 | -0.19% | ✗ | $21.5K |
| Mar 3, 2023 | Mar 7, 2023 | Tourmaline Bio, Inc. | Director | Sell | 51.3 | -6,806 | -0.12% | ✗ | $14K |
| Mar 1, 2023 | Mar 2, 2023 | Tourmaline Bio, Inc. | Director | Sell | 52.5 | -29 | 0.00% | ✗ | $59.5 |
| Feb 21, 2023 | Feb 23, 2023 | Tourmaline Bio, Inc. | Director | Sell | 52.5 | -3,500 | -0.06% | ✗ | $7.2K |
| Feb 16, 2023 | Feb 21, 2023 | Tourmaline Bio, Inc. | Director | Sell | 51.3 | -6,551 | -0.12% | ✗ | $13.4K |
| Aug 22, 2022 | Aug 23, 2022 | Tourmaline Bio, Inc. | Chief Scientific Officer | Sell | 17.5 | -525,000 | -8.59% | ✗ | $1.5M |